Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). - Luvira V; Lawpoolsri S; Phumratanaprapin W; Jongkaewwattana A; Nanthapisal S; Muangnoicharoen S; Kamolratanakul S; Sabmee Y; Duangdee C; Narakorn P; Surichan S; Mercer LD; et al. (Vaccine, 2025)